Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Sci Rep ; 12(1): 1856, 2022 02 03.
Artigo em Inglês | MEDLINE | ID: mdl-35115644

RESUMO

Severe COVID-19 is associated with a systemic hyperinflammatory response leading to acute respiratory distress syndrome (ARDS), multi-organ failure, and death. Galectin-3 is a ß-galactoside binding lectin known to drive neutrophil infiltration and the release of pro-inflammatory cytokines contributing to airway inflammation. Thus, we aimed to investigate the potential of galectin-3 as a biomarker of severe COVID-19 outcomes. We prospectively included 156 patients with RT-PCR confirmed COVID-19. A severe outcome was defined as the requirement of invasive mechanical ventilation (IMV) and/or in-hospital death. A non-severe outcome was defined as discharge without IMV requirement. We used receiver operating characteristic (ROC) and multivariable logistic regression analysis to determine the prognostic ability of serum galectin-3 for a severe outcome. Galectin-3 levels discriminated well between severe and non-severe outcomes and correlated with markers of COVID-19 severity, (CRP, NLR, D-dimer, and neutrophil count). Using a forward-stepwise logistic regression analysis we identified galectin-3 [odds ratio (OR) 3.68 (95% CI 1.47-9.20), p < 0.01] to be an independent predictor of severe outcome. Furthermore, galectin-3 in combination with CRP, albumin and CT pulmonary affection > 50%, had significantly improved ability to predict severe outcomes [AUC 0.85 (95% CI 0.79-0.91, p < 0.0001)]. Based on the evidence presented here, we recommend clinicians measure galectin-3 levels upon admission to facilitate allocation of appropriate resources in a timely manner to COVID-19 patients at highest risk of severe outcome.


Assuntos
COVID-19/diagnóstico , COVID-19/virologia , Galectinas/sangue , SARS-CoV-2 , Adulto , Idoso , Biomarcadores/sangue , Proteínas Sanguíneas , COVID-19/complicações , COVID-19/imunologia , Citocinas/metabolismo , Feminino , Humanos , Inflamação , Mediadores da Inflamação/metabolismo , Masculino , Pessoa de Meia-Idade , Infiltração de Neutrófilos , Gravidade do Paciente , Valor Preditivo dos Testes , Prognóstico , Estudos Prospectivos , Síndrome do Desconforto Respiratório/etiologia , Risco
2.
Childs Nerv Syst ; 35(6): 917-927, 2019 06.
Artigo em Inglês | MEDLINE | ID: mdl-30953157

RESUMO

PURPOSE: Intraventricular hemorrhage is the most important adverse neurologic event for preterm and very low weight birth infants in the neonatal period. This pathology can lead to various delays in motor, language, and cognition development. The aim of this article is to give an overview of the knowledge in diagnosis, classification, and treatment options of this pathology. METHOD: A systematic review has been made. RESULTS: The cranial ultrasound can be used to identify the hemorrhage and grade it according to the modified Papile grading system. There is no standardized protocol of intervention as there are controversial results on which of the temporizing neurosurgical procedures is best and about the appropriate parameters to consider a conversion to ventriculoperitoneal shunt. However, it has been established that the most important prognosis factor is the involvement and damage of the white matter. CONCLUSION: More evidence is required to create a standardized protocol that can ensure the best possible outcome for these patients.


Assuntos
Hemorragia Cerebral Intraventricular/classificação , Hemorragia Cerebral Intraventricular/diagnóstico , Hemorragia Cerebral Intraventricular/terapia , Doenças do Prematuro/classificação , Doenças do Prematuro/diagnóstico , Doenças do Prematuro/terapia , Feminino , Humanos , Hidrocefalia/etiologia , Hidrocefalia/terapia , Recém-Nascido , Recém-Nascido Prematuro , Masculino
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA